Home
Conditions
Purpura, Thrombocytopenic

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

339 public trials 90 recruiting studies

Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Not Yet Recruiting

Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP

NCT07662525

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Not Yet Recruiting

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

NCT07622329

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

NCT07574073

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +22 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Universal STAR-T Cell Injection in R/R Autoimmune Diseases.

NCT07599280

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: No. 28, Fuxing Road, Haidian District, Beijing, China. Haidian, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

ATRA for Management of Primary ITP

NCT07597395

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Peking University Institute of hematology, People's Hospital Beijing, China

View Trial Details

Not Yet Recruiting

TGD001 Treatment in Thrombotic Microangiopathies

NCT07459114

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

NCT07455006

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization

NCT07426107

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Autoimmune Diseases, +24 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

NCT07416032

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

NCT07400250

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Purpura, Thrombocytopenic

Purpura, Thrombocytopenic trial results

Related conditions